{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:06:41Z","timestamp":1787317601460,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-03087-4","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:09:17Z","timestamp":1732054157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence, prognostic and clinicopathological value of HIF-1\u03b1 in glioblastoma patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Hao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"3087_CR1","doi-asserted-by":"publisher","unstructured":"Schaff LR, Mellinghoff IK (2023) \u2018Glioblastoma and Other Primary Brain Malignancies in Adults: A Review\u2019, JAMA, vol. 329, no. 7, pp. 574\u2013587, Feb. https:\/\/doi.org\/10.1001\/jama.2023.0023","DOI":"10.1001\/jama.2023.0023"},{"key":"3087_CR2","doi-asserted-by":"publisher","unstructured":"Rong L, Li N, Zhang Z (Apr. 2022) Emerging therapies for glioblastoma: current state and future directions. J Experimental Clin Cancer Res 41(1):142. https:\/\/doi.org\/10.1186\/s13046-022-02349-7","DOI":"10.1186\/s13046-022-02349-7"},{"key":"3087_CR3","doi-asserted-by":"publisher","unstructured":"Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H (2021) \u2018Current Immunotherapies for Glioblastoma Multiforme\u2019, Frontiers in Immunology, vol. 11, [Online]. Available: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2020.603911","DOI":"10.3389\/fimmu.2020.603911"},{"key":"3087_CR4","doi-asserted-by":"publisher","unstructured":"Ostrom QT et al (2019) \u2018CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012\u20132016\u2019, Neuro-Oncology, vol. 21, no. Supplement_5, pp. v1\u2013v100, Nov. https:\/\/doi.org\/10.1093\/neuonc\/noz150","DOI":"10.1093\/neuonc\/noz150"},{"key":"3087_CR5","doi-asserted-by":"publisher","unstructured":"Verdugo E, Puerto I, Medina M\u00c1 (2022) \u2018An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment\u2019, Cancer Communications, vol. 42, no. 11, pp. 1083\u20131111, Nov. https:\/\/doi.org\/10.1002\/cac2.12361","DOI":"10.1002\/cac2.12361"},{"issue":"4","key":"3087_CR6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1039\/D1BM01401C","volume":"10","author":"R Li","year":"2022","unstructured":"Li R, Wang H, Qing L, Lian C, Ren J (2022) Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies. Oncol Lett 10(4):892\u2013908. https:\/\/doi.org\/10.1039\/D1BM01401C","journal-title":"Oncol Lett"},{"key":"3087_CR7","doi-asserted-by":"publisher","unstructured":"Ke Q, Costa M (2006) \u2018Hypoxia-Inducible Factor-1 (HIF-1)\u2019, Mol Pharmacol, vol. 70, no. 5, p. 1469, Nov. https:\/\/doi.org\/10.1124\/mol.106.027029","DOI":"10.1124\/mol.106.027029"},{"key":"3087_CR8","doi-asserted-by":"publisher","unstructured":"Srivastava C et al (2018) Feb., \u2018FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma\u2019, International Journal of Cancer, vol. 142, no. 4, pp. 805\u2013812, https:\/\/doi.org\/10.1002\/ijc.31092","DOI":"10.1002\/ijc.31092"},{"key":"3087_CR9","doi-asserted-by":"publisher","unstructured":"Agrawal R, Pandey P, Jha P, Dwivedi V, Sarkar C, Kulshreshtha R (Aug. 2014) Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. BMC Genomics 15(1):686. https:\/\/doi.org\/10.1186\/1471-2164-15-686","DOI":"10.1186\/1471-2164-15-686"},{"key":"3087_CR10","doi-asserted-by":"publisher","unstructured":"Chen Z, Su S, Yang M, Wang F, Chen M (2022) \u2018Profiling and Bioinformatics Analyses of Differential Circular RNA Expression in Glioblastoma Multiforme Cells Under Hypoxia\u2019, Journal of Molecular Neuroscience, vol. 72, no. 12, pp. 2451\u20132463, Dec. https:\/\/doi.org\/10.1007\/s12031-022-02090-y","DOI":"10.1007\/s12031-022-02090-y"},{"key":"3087_CR11","doi-asserted-by":"publisher","unstructured":"Gabriely G, Wheeler MA, Takenaka MC, Quintana FJ (2017) \u2018Role of AHR and HIF-1\u03b1 in Glioblastoma Metabolism\u2019, Trends in Endocrinology & Metabolism, vol. 28, no. 6, pp. 428\u2013436, Jun. https:\/\/doi.org\/10.1016\/j.tem.2017.02.009","DOI":"10.1016\/j.tem.2017.02.009"},{"key":"3087_CR12","doi-asserted-by":"publisher","unstructured":"Stroup DF et al (2000) Apr., \u2018Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting\u2019, JAMA, vol. 283, no. 15, pp. 2008\u20132012, https:\/\/doi.org\/10.1001\/jama.283.15.2008","DOI":"10.1001\/jama.283.15.2008"},{"key":"3087_CR13","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group TPRISMA (2009) \u2018Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement\u2019, PLOS Medicine, vol. 6, no. 7, p. e1000097, Jul. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","DOI":"10.1371\/journal.pmed.1000097"},{"key":"3087_CR14","doi-asserted-by":"publisher","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) \u2018Practical methods for incorporating summary time-to-event data into meta-analysis\u2019, Trials, vol. 8, no. 1, p. 16, Jun. https:\/\/doi.org\/10.1186\/1745-6215-8-16","DOI":"10.1186\/1745-6215-8-16"},{"key":"3087_CR15","doi-asserted-by":"publisher","unstructured":"Stang A (2010) \u2018Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses\u2019, European Journal of Epidemiology, vol. 25, no. 9, pp. 603\u2013605, Sep. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","DOI":"10.1007\/s10654-010-9491-z"},{"key":"3087_CR16","doi-asserted-by":"crossref","unstructured":"Sfifou F et al (2021) \u2018Correlation of immunohistochemical expression of HIF-1alpha and IDH1 with clinicopathological and therapeutic data of moroccan glioblastoma and survival analysis\u2019, Annals of Medicine and Surgery, vol. 69, [Online]. Available: https:\/\/journals.lww.com\/annals-of-medicine-and-surgery\/fulltext\/2021\/09000\/correlation_of_immunohistochemical_expression_of.57.aspx","DOI":"10.1016\/j.amsu.2021.102731"},{"key":"3087_CR17","doi-asserted-by":"publisher","unstructured":"Ji X et al (2013) Dec., \u2018Correlation of Nrf2 and HIF-1\u03b1 in glioblastoma and their relationships to clinicopathologic features and survival\u2019, Neurological Research, vol. 35, no. 10, pp. 1044\u20131050, https:\/\/doi.org\/10.1179\/1743132813Y.0000000251","DOI":"10.1179\/1743132813Y.0000000251"},{"key":"3087_CR18","doi-asserted-by":"publisher","unstructured":"Irshad K et al (Mar. 2015) A combined gene signature of Hypoxia and Notch Pathway in Human Glioblastoma and its prognostic relevance. PLoS ONE 10(3):e0118201. https:\/\/doi.org\/10.1371\/journal.pone.0118201","DOI":"10.1371\/journal.pone.0118201"},{"key":"3087_CR19","doi-asserted-by":"publisher","unstructured":"Flynn JR et al (2008) Sep., \u2018Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme\u2019, Cancer, vol. 113, no. 5, pp. 1032\u20131042, https:\/\/doi.org\/10.1002\/cncr.23678","DOI":"10.1002\/cncr.23678"},{"key":"3087_CR20","doi-asserted-by":"publisher","unstructured":"Chen W et al (2019) Mar., \u2018Clinical implications of hypoxia\u2013inducible factor\u20131\u03b1 and caveolin\u20131 overexpression in isocitrate dehydrogenase\u2013wild type glioblastoma multiforme\u2019, Oncol Lett, vol. 17, no. 3, pp. 2867\u20132873, https:\/\/doi.org\/10.3892\/ol.2019.9929","DOI":"10.3892\/ol.2019.9929"},{"key":"3087_CR21","doi-asserted-by":"publisher","unstructured":"Burgess ER et al (2022) \u2018Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival\u2019, Frontiers in Oncology, vol. 12, [Online]. Available: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/https:\/\/doi.org\/10.3389\/fonc.2022.829524","DOI":"10.3389\/fonc.2022.829524"},{"issue":"11","key":"3087_CR22","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.7150\/jca.32909","volume":"10","author":"M Potharaju","year":"2019","unstructured":"Potharaju M et al (2019) Clinicopathological analysis of HIF-1alpha and TERT on Survival Outcome in Glioblastoma patients: a prospective, single Institution Study. J Cancer 10(11):2397\u20132406","journal-title":"J Cancer"},{"key":"3087_CR23","doi-asserted-by":"publisher","unstructured":"Irie N, Matsuo T, Nagata I (Feb. 2004) Protocol of radiotherapy for glioblastoma according to the expression of HIF-1. Brain Tumor Pathol 21(1):1\u20136. https:\/\/doi.org\/10.1007\/BF02482169","DOI":"10.1007\/BF02482169"},{"key":"3087_CR24","doi-asserted-by":"crossref","unstructured":"Clara CA et al (2024) \u2018Angiogenesis and glioblastoma.Carlos Afonso Clara, Suely K.N. Marie, Jos\u00e9 Reynaldo Walther de Almeida, Alda Wakamatsu, Sueli Mieko Oba-Shinjo, Miyuki Uno, Munro Neville, S\u00e9rgio Rosemberg\u2019, Neuropathology, no. 34, pp. 343\u2013352","DOI":"10.1111\/neup.12111"},{"key":"3087_CR25","doi-asserted-by":"publisher","unstructured":"Zhang X et al (Sep. 2018) Yes-associated protein (YAP) binds to HIF-1\u03b1 and sustains HIF-1\u03b1 protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. J Experimental Clin Cancer Res 37(1):216. https:\/\/doi.org\/10.1186\/s13046-018-0892-2","DOI":"10.1186\/s13046-018-0892-2"},{"key":"3087_CR26","doi-asserted-by":"publisher","unstructured":"He Q et al (2021) \u2018Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1\u03b1 in Ischemic Stroke\u2019, Frontiers in Immunology, vol. 12, [Online]. Available: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2021.801985","DOI":"10.3389\/fimmu.2021.801985"},{"key":"3087_CR27","doi-asserted-by":"publisher","unstructured":"Zampell JC, Yan A, Avraham T, Daluvoy S, Weitman ES, Mehrara BJ (2012) \u2018HIF-1\u03b1: coordinates lymphangiogenesis during wound healing and in response to inflammation\u2019, The FASEB Journal, vol. 26, no. 3, pp. 1027\u20131039, Mar. https:\/\/doi.org\/10.1096\/fj.11-195321","DOI":"10.1096\/fj.11-195321"},{"key":"3087_CR28","doi-asserted-by":"publisher","unstructured":"Dom\u00e8nech M, Hern\u00e1ndez A, Plaja A, Mart\u00ednez-Balibrea E, Bala\u00f1\u00e0 C (2021) \u2018Hypoxia: The Cornerstone of Glioblastoma\u2019, International Journal of Molecular Sciences, vol. 22, no. 22, https:\/\/doi.org\/10.3390\/ijms222212608","DOI":"10.3390\/ijms222212608"},{"key":"3087_CR29","doi-asserted-by":"crossref","unstructured":"Guo R, Yang B (2021) \u2018Hypoxia-Induced LXR\u03b1 Contributes to the Migration and Invasion of Gastric Cancer Cells.\u2019, Folia Biologica (00155500), vol. 67, no. 3","DOI":"10.14712\/fb2021067030091"},{"key":"3087_CR30","doi-asserted-by":"publisher","unstructured":"Wang X-W, Fu H, Zhang Y-M (May 2024) HIF-1\u03b1 facilitates glioma proliferation and invasion by activating pyroptosis signaling axis. Chin Neurosurgical J 10(1):14. https:\/\/doi.org\/10.1186\/s41016-024-00366-3","DOI":"10.1186\/s41016-024-00366-3"},{"key":"3087_CR31","doi-asserted-by":"publisher","unstructured":"Wang G, Wang J-J, Fu X-L, Guang R, To Tony S-S (2017) \u2018Advances in the targeting of HIF-1\u03b1 and future therapeutic strategies for glioblastoma multiforme (Review)\u2019, Oncol Rep, vol. 37, no. 2, pp. 657\u2013670, Feb. https:\/\/doi.org\/10.3892\/or.2016.5309","DOI":"10.3892\/or.2016.5309"},{"key":"3087_CR32","doi-asserted-by":"publisher","unstructured":"Shen SH, Kwan AL, Chen YY, Wang ZX (2013) \u2018Effect of silencing HIF-1\u03b1 on proliferation, invasion and migration of glioblastoma U87 cells\u2019, Neurological Sciences, vol. 34, no. 3, pp. 365\u2013371, Mar. https:\/\/doi.org\/10.1007\/s10072-012-1010-4","DOI":"10.1007\/s10072-012-1010-4"},{"key":"3087_CR33","doi-asserted-by":"publisher","unstructured":"Xie Q et al (2019) Feb., \u2018DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1\u0391 Based on MRI-Neuronavigation Stereotactic Biopsies\u2019, Academic Radiology, vol. 26, no. 2, pp. 179\u2013187, https:\/\/doi.org\/10.1016\/j.acra.2018.04.015","DOI":"10.1016\/j.acra.2018.04.015"},{"key":"3087_CR34","doi-asserted-by":"publisher","unstructured":"Rashid M et al (2021) Sep., \u2018Up-down regulation of HIF-1\u03b1 in cancer progression\u2019, Gene, vol. 798, p. 145796, https:\/\/doi.org\/10.1016\/j.gene.2021.145796","DOI":"10.1016\/j.gene.2021.145796"},{"key":"3087_CR35","doi-asserted-by":"publisher","unstructured":"Chowdhury M, Das PK (2024) \u2018Hypoxia: Intriguing Feature in Cancer Cell Biology\u2019, ChemMedChem, vol. 19, no. 9, p. e202300551, May https:\/\/doi.org\/10.1002\/cmdc.202300551","DOI":"10.1002\/cmdc.202300551"},{"key":"3087_CR36","doi-asserted-by":"publisher","unstructured":"Jackson CM, Choi J, Lim M (2019) \u2018Mechanisms of immunotherapy resistance: lessons from glioblastoma\u2019, Nature Immunology, vol. 20, no. 9, pp. 1100\u20131109, Sep. https:\/\/doi.org\/10.1038\/s41590-019-0433-y","DOI":"10.1038\/s41590-019-0433-y"},{"key":"3087_CR37","doi-asserted-by":"publisher","unstructured":"Noch EK, Ramakrishna R, Magge R (2018) \u2018Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance\u2019, World Neurosurgery, vol. 116, pp. 505\u2013517, Aug. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.022","DOI":"10.1016\/j.wneu.2018.04.022"},{"key":"3087_CR38","doi-asserted-by":"publisher","unstructured":"Zhang Z et al (2015) Sep., \u2018Proteolytic Cleavage of AMPK\u03b1 and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1\u03b1 Expression in Leukocytes\u2019, The Journal of Immunology, vol. 195, no. 5, pp. 2452\u20132460, https:\/\/doi.org\/10.4049\/jimmunol.1500944","DOI":"10.4049\/jimmunol.1500944"},{"key":"3087_CR39","doi-asserted-by":"publisher","unstructured":"Pajak B et al (2020) 2-Deoxy-d-Glucose and its analogs: from Diagnostic to Therapeutic agents. Int J Mol Sci 21(1). https:\/\/doi.org\/10.3390\/ijms21010234","DOI":"10.3390\/ijms21010234"},{"key":"3087_CR40","doi-asserted-by":"publisher","unstructured":"Proto MC, Fiore D, Piscopo C, Laezza C, Bifulco M, Gazzerro P (2022) \u2018Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases\u2019, Frontiers in Pharmacology, vol. 13, [Online]. Available: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2022.815646","DOI":"10.3389\/fphar.2022.815646"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-03087-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:35:36Z","timestamp":1741066536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-03087-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3087"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-03087-4","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require ethics approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study did not include any personal data, including personal details, images or videos, and no children participated. Therefore, consent for publication is not applicable in this context.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"860"}}